Early identification of infectious complications in lung transplant recipients using procalcitonin

Transplant Infectious Disease

Volumn 14, Issue 5, 2012, Pages 461-467

  Suberviola, B ^a   Castellanos Ortega, A ^a   Ballesteros, M A ^a   Zurbano, F ^a   Naranjo, S ^a   Minambres E ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

C reactive protein; Infection; Lung; Procalcitonin; Transplantation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; STEROID; TACROLIMUS;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; OBSERVATIONAL STUDY; PERITONITIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INFECTION; LEUKOCYTE COUNT; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE;

EID: 84867635465     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00780.x     Document Type: Article

References (35)

1. Miñambres E, Zurbano F, Naranjo S, Llorca J, Cifrián JM, González-Castro A. Mortality analysis of patients undergoing lung transplantation for emphysema. Arch Bronconeumol 2009; 45: 335-340.
2. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eight official adult lung and heart-lung transplant report-2011. J Heart Lung Transplant 2011; 30: 1104-1122.
3. González-Castro A, Díaz-Regañón G, Fernández-Miret B, Suberviola-Cañas B, Llorca J, Miñambres E. [External validation of the risk quantification of early outcome after lung transplantation scale.] Med Intensiva 2010; 34: 446-452.
4. Mangi AA, Mason DP, Nowicki ER, et al. Predictors of acute rejection after lung transplantation. Ann Thorac Surg 2011; 91: 1754-1762.
5. Whitson BA, Prekker ME, Herrington CS, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007; 26: 1004-1011.
6. Becker KL, Nylén ES, White JC, Müller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512-1525.
7. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26 (Suppl 2): S148-S152.
8. Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 2009; 139: 318-326.
9. Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-1256.
10. Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-5584.
11. Claessens YE, Mathevon T, Kierzek G, et al. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med 2010; 36: 799-709.
12. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607.
13. Hammer S, Meisner F, Dirschedl P, et al. Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 1998; 6: 235-241.
14. Hammer S, Meisner F, Dirschedl P, et al. Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts. Intensive Care Med 2000; 26 (Suppl 2): S182-S186.
15. Suberviola Cañas B, González Castro A, Holanda Peña MS, Fernández Miret B. [Usefulness of procalcitonin in the diagnosis of infection in lung transplant patients.] Med Intensiva 2009; 33: 358-359.
16. Spanish National Transplant Organization website. Available at http://www.ont.es/infesp/Paginas/DatosdeDonacionyTrasplante.aspx.
17. Shargall Y, Guenther G, Ahya VN, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. J Heart Lung Transplant 2005; 24: 1489-1500.
18. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Disease Society of America. Clin Infect Dis 2009; 49: 1-45.
19. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996; 224: 10-18.
20. Jaresová M, Stríz I, Cermáková J, et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol Lett 1999; 69: 355-358.
21. de Kruif MD, Lemaire LC, Giebelen IA, et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 2008; 34: 518-522.
22. Staehler M, Hammer C, Meiser B, Reichart B. Procalcitonin: a new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant Proc 1997; 29: 584-585.
23. Adamik B, Kübler-Kielb J, Golebiowska B, Gamian A, Kübler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000; 26: 1259-1267.
24. Falcoz PE, Laluc F, Toubin MM, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg 2005; 27: 1074-1078.
25. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
26. Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA, Hoksch B. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 2008; 33: 777-780.
27. Perrakis A, Yedibela S, Schellerer V, Hohenberger W, Müller V. Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc 2010; 42: 4187-4190.
28. Madershahian N, Wittwer T, Strauch J, et al. Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg 2008; 23: 468-473.
29. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg 2000; 8: 550-554.
30. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 2011; 27: 253-263.
31. Suberviola B, Castellanos-Ortega A, González-Castro A, García-Astudillo LA, Fernández-Miret B. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock.] Med Intensiva 2012; 36: 177-184. Epub 4 November 2011.
32. Castelli GP, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009; 37: 1845-1849.
33. Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, et al. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 2011; 26: 331.
34. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375: 463-474.
35. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012; 141: 1063-1073.